ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
Dow Jones
40,003.59
0.34%
Brent Oil
83.76
0.00%
Bitcoin
67,122.84
0.06%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Mind Medicine MindMed Inc (MNMD) Quote

Mind Medicine MindMed Inc

Mind Medicine MindMed Inc (MNMD)

NASDAQ
8.22
-0.43
(-4.97%)
Closed May 18 4:00PM
Delayed by 15 minutes
8.4197
0.1997
(2.43%)
After Hours: 7:45PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
8.4197
Bid
8.28
Ask
8.39
Volume
1,009,949
8.22 Day's Range 8.685
2.41 52 Week Range 12.22
Market Cap
2.893M
Previous Close
8.65
Open
8.67
Last Trade
7
@
8.39
Last Trade Time
Financial Volume
$ 8,464,303
VWAP
8.3809
Average Volume (3m)
2,479,683
Shares Outstanding
41,334,307
Dividend Yield
-
PE Ratio
-0.03
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-95.73M

About Mind Medicine MindMed Inc

Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances inclu... Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies. Show more

Sector
Pharmaceutical Preparations
Industry
Unit Inv Tr, Closed-end Mgmt
Website
www.mindmed.com
Headquarters
Vancouver, British Columbia, Can
Founded
2013
Mind Medicine MindMed Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MNMD. The last closing price for Mind Medicine MindMed was $8.65. Over the last year, Mind Medicine MindMed shares have traded in a share price range of $ 2.41 to $ 12.22.

Mind Medicine MindMed currently has 41,334,307 shares outstanding. The market capitalization of Mind Medicine MindMed is $2.89 million. Mind Medicine MindMed has a price to earnings ratio (PE ratio) of -0.03.

MNMD Latest News

More News

MindMed to Participate at May Investor Conferences

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced...

May 09 2024
Business Wire

New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US

-GAD Diagnosis Increases Healthcare Costs and Decreases Work Productivity and Health-Related Quality of Life- -People with Undiagnosed GAD Incur Even Higher Total Healthcare Costs than those...

May 09 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 08 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 08 2024
Edgar (US Regulatory)

MindMed Reports First Quarter 2024 Financial Results and Business Updates

--Announced positive Phase 2b clinical trial results for MM120 in Generalized Anxiety Disorder (GAD), demonstrating clinically and statistically significant activity through 12 weeks after...

May 08 2024
Business Wire

MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

-A single oral administration of MM120 100 µg met its primary and key secondary endpoints and maintained clinically and statistically significant HAM-A reductions compared to placebo at 12 weeks...

May 04 2024
Business Wire

MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced...

May 02 2024
Business Wire

MindMed to Present at Upcoming May Medical Conferences

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders...

April 25 2024
Business Wire

MindMed to Present at Upcoming April Medical Conferences

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (Cboe Canada: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain...

April 02 2024
Business Wire

MindMed Announces Voluntary Delisting from Cboe Canada

All Common shares will remain listed on Nasdaq Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing...

April 01 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.7303-7.981420765039.159.398.2211073138.79175432CS
4-0.3803-4.321590909098.810.347.950111604339.04640288CS
123.619775.41041666674.812.224.6624796839.17623313CS
265.9397239.5040322582.4812.222.4415318357.95808548CS
525.3897177.8778877893.0312.222.419903336.97348034CS
156-45.7303-84.451154201354.1560.62.12293747424.17123967CS
260-76.8808-90.129366181985.300586.552.12322508127.68762309CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DUOFangDD Network Group Ltd
$ 1.65
(313.74%)
104.68M
FLJFLJ Group Limited
$ 1.54
(220.90%)
57.28M
JFBRJeffs Brands Ltd
$ 0.6276
(102.45%)
37.97M
IPWiPower Inc
$ 2.89
(97.95%)
11.05M
CETXCemtrex Inc
$ 0.4851
(48.58%)
21.23M
BSFCBlue Star Foods Corporation
$ 0.0757
(-45.26%)
60.09M
SINTSiNtx Technologies Inc
$ 0.084602
(-39.57%)
156.35M
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
HSCSHeart Test Laboratories Inc
$ 7.00
(-38.11%)
348.9k
AMPGAmplitech Group Inc
$ 1.46
(-32.09%)
613.31k
CRKNCrown Electrokinetics Corporation
$ 0.171
(-28.75%)
1.74B
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
GWAVGreenwave Technology Solutions Inc
$ 0.1541
(4.05%)
1.16B
AKANAkanda Corporation
$ 0.1726
(30.26%)
566.51M
PEGYPineapple Energy Inc
$ 0.1053
(-28.85%)
219.25M

MNMD Discussion

View Posts
Tiger Money Tiger Money 5 days ago
This stock may need a little of its own medicine:)
👍️0
Tiger Money Tiger Money 7 days ago
This stock is resilient. Tells me the institutional longs have no desire to sell until we are significantly higher. $50-100 range. The market for their product is almost Infiniti
👍️0
Tiger Money Tiger Money 1 week ago
Agreed
👍️ 1 🫡 1
Savannah-Marc Savannah-Marc 1 week ago
MNMD recovering!
Bullish!!!!!!!!!!!!!!!!!!!!!
👍️ 1 💥 1
Savannah-Marc Savannah-Marc 1 week ago
Multi-billion dollar valuations are approaching.
https://www.businesswire.com/news/home/20240508064415/en/MindMed-Reports-First-Quarter-2024-Financial-Results-and-Business-Updates
👍️ 1 📈 1 🤡 1
burner67 burner67 2 weeks ago
Not a lie. Completely different drugs. Do you have Google Marc?
💩 1 🤡 1
Savannah-Marc Savannah-Marc 2 weeks ago
And I quote:

Savannah-Marc
04/14/24 2:40 PM
Post #9,370
Keep your eye on the prize my fellow MindMed shareholders. A company with a similar profile was bought out for $14 billion while still in FDA Phase 3 clinical trials and WITHOUT FDA Breakthrough designation! Know what you own! Stay well my people!
https://www.biopharmadive.com/news/bristol-myers-karuna-acquire-schizophrenia-kar-xt/703313/
🌋 1 👍️ 1
Savannah-Marc Savannah-Marc 2 weeks ago
You say things and spin lies like they matter. Your opinions are worthless on whatever board you try and yuck it up on. Stick to giving "stock tips" from the drive thru window and don't forget the ketchup packets, that's the most important part!
🍟 1 👍️ 1
burner67 burner67 2 weeks ago
How are they similar? Because they're both in phase 3? You could say that about hundreds of drugs. KarXT is NOT a psychedelic while MindMed's drugs are all pcychedelics, so not similar.
💩 1 🤡 1
burner67 burner67 2 weeks ago
Typical response 🤣
👍️0
Savannah-Marc Savannah-Marc 2 weeks ago
AWESOME!!!!!
👍️ 1 😎 1
MomsSpaghetti MomsSpaghetti 2 weeks ago
MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York

https://finance.yahoo.com/news/mindmed-presents-phase-2b-study-120000301.html
👍️ 1 🥇 1
MomsSpaghetti MomsSpaghetti 2 weeks ago
I have never seen a PR on a Saturday.
👍️ 1 🤩 1
Monksdream Monksdream 2 weeks ago
MNMD 10 day hourly
👍️ 1 📈 1
Tiger Money Tiger Money 2 weeks ago
I think so
👍️ 1 💯 1
Monksdream Monksdream 2 weeks ago
Maybe back to $12 next week
👍️ 1 📈 1
Savannah-Marc Savannah-Marc 2 weeks ago
MindMed will be the vanguard of the shroom boom, only a matter of time before this trades in the BILLIONS!!!!!
👍️ 1 🤡 1 🥇 1
Tiger Money Tiger Money 2 weeks ago
Agreed
👍️ 1 🫡 1
MomsSpaghetti MomsSpaghetti 2 weeks ago
Primed to go sky high. This along with ATAI will be big players in this market. Also, while not related but will be a catalyst is the fact they are going to deschedule Cannabis. This is huge for this sector because of optics.
👍️ 1 💯 1
BefallenKnight BefallenKnight 3 weeks ago
Supposed “Special Meeting” on June 9
As seen on Reddit/WeBull
👍️ 1 🤩 1
Savannah-Marc Savannah-Marc 3 weeks ago
I believe MindMed's FDA Breakthrough designation is going to increase value at breakneck speeds.
https://www.fool.com/investing/2024/04/25/this-small-cap-stock-is-up-150-this-year-and-heres/
👍️ 1 🚀 1
Savannah-Marc Savannah-Marc 3 weeks ago
Another recent bullish article.
https://investorplace.com/2024/04/the-top-3-small-cap-stocks-to-buy-in-april-2024/
👍️ 2 📈 1
Savannah-Marc Savannah-Marc 3 weeks ago
Shroom boom is coming, only a matter of time!
https://www.nationalgeographic.com/premium/article/psychedelic-medicine-veterans-ptsd-anxiety-depression
👍️ 1 💥 1 😴 1
Savannah-Marc Savannah-Marc 4 weeks ago
Stop making shittz up! This stock is EASY $30 per share by measuring it to other companies that were in similiar circumstances such as ENTERING FDA PHASE 3 and ACHIEVING FDA BREAKTHROUGH DESIGNATION! MindMed is wayyyyyyy UNDERVALUED!!!!!
👍️ 1 🤡 2 🥇 1
BefallenKnight BefallenKnight 4 weeks ago
Only if Re/De-Scheduled or Major News
This was overbought after the FDA breakthrough announcement, and rightfully so because barring the dilution MNMD would probably be on the moon by now at 25-50pps

I think MNMD drifts a bit and worst case closes the big gap at 6-7pps. This is only short term as I full expected a moonshot here once Phase 3 news starts to materialize and eventually more info on MM-120 getting to market.

In the meantime, this volatility is excellent for generating cash. I’m not usually a day trader but it’s pretty easy to scalp a couple hundred $ and sometimes a few thousand per day by selling covered calls. I would never short the equity or sell naked calls on a biopharma but sell covered calls, close the intraday or next day, rinse and repeat.

Good times!
💩 1 🤡 1
LORTAP KCOTS LORTAP KCOTS 4 weeks ago
Oversold, ready for a bounce back to $11
👍️ 1 💯 1
Monksdream Monksdream 4 weeks ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
MomsSpaghetti MomsSpaghetti 1 month ago
Watch this.... https://www.hcplive.com/view/daniel-karlin-md-fda-grants-breakthrough-designation-to-mm120-for-anxiety
👍️ 2 🤩 1
MomsSpaghetti MomsSpaghetti 1 month ago
No worries here my friend. Keep buying on this side!
👍️ 1 💯 1
Savannah-Marc Savannah-Marc 1 month ago
Keep your eye on the prize my fellow MindMed shareholders. A company with a similar profile was bought out for $14 billion while still in FDA Phase 3 clinical trials and WITHOUT FDA Breakthrough designation! Know what you own! Stay well my people!
https://www.biopharmadive.com/news/bristol-myers-karuna-acquire-schizophrenia-kar-xt/703313/
🏆️ 1 👍️ 2
BefallenKnight BefallenKnight 1 month ago
Closed the Calls at .4
I’m happy with the returns but not too happy with the overall close for the week. Losing the 10 mark is always unsettling. Short term I would not be surprised to see MNMD drift lower. There are rumblings about significant federal action next week to re or de-schedule cannabis and psychs but that’s nothing new until the government finally takes action with legislation. For reals tho, if the FDA is saying psyches and cannabis have medical applications it’s about f**king time to do something. It would be incredibly embarrassing, and a potential liability if MNMD had a great Phase 3 trials and was ready to go to market but inane, outdated laws prevented the company from doing so!
💩 1 🤡 1
Nosnibor Nosnibor 1 month ago
Vomit.
👍️ 1 💩 1 🤡 1 ♥️ 1
BefallenKnight BefallenKnight 1 month ago
So Close to Covering My Short Calls
Since the FDA BTD designation I’ve been hammering the Apr 19 10c….sell to open, buy to close, profit, rinse and repeat. Easy money with the recent volatility. I’m on what will be my final trade on those covered calls….sold to open last week, 10 contracts for 1.75per. This dip may be the opportunity to close but I’m looking to cover at .50 or lower. Even though I’m fine selling at 10pps I really don't want the shares to be called away. Either way, I’m stoked and this volatility is awesome!
💩 1 🤡 1
BefallenKnight BefallenKnight 1 month ago
So Close to Covering My Short Calls
Since the FDA BTD designation I’ve been hammering the Apr 19 10c….sell to open, buy to close, profit, rinse and repeat. Easy money with the recent volatility. I’m on what will be my final trade on those covered calls….sold to open last week, 10 contracts for 1.75per. This dip may be the opportunity to close but I’m looking to cover at .50 or lower. Even though I’m fine selling at 10pps I really don't want the shares to be called away. Either way, I’m stoked and this volatility is awesome!
💩 1 🤡 1
Savannah-Marc Savannah-Marc 1 month ago
Buck Yeah! This article compares MindMed to Gold and Costco! Yacht Week is coming soon!!!!!!!
https://moneymorning.com/2024/04/10/three-stocks-mindmed-gold-and-costco/
👍️ 1 💰️ 1 🤡 1
Savannah-Marc Savannah-Marc 1 month ago
High times ahead.....for the share price lol
👍️ 1 📈 1 🤡 1
Tiger Money Tiger Money 1 month ago
That is huge if true!
👍️ 1 🤗 1
BefallenKnight BefallenKnight 1 month ago
News Coming Over the Next Few Days?
Rumblings about some major changes coming to over the next week.

Some of the CA dispensary owners I consult with have been told by the state that there is eminent federal action.

Not sure what this means but might be the big one we’ve all been waiting for
👍️ 1 💲 1
Savannah-Marc Savannah-Marc 1 month ago
Shroom Boom incoming.....but only for MindMed!!!!!!!!!!
👍️ 1 📈 1 🤡 1 🤣 1
BubbaInSC BubbaInSC 1 month ago
lol true dat

go big or go home! :)

I’m cool with it sitting here for a bit, as we all know it’s either gonna be a 100x or bust
👍️ 1 💰️ 1
retireat40 retireat40 1 month ago
They now look a lot worse. Had to sell my calls at a small loss. Can’t take the risk.
👍️0
retireat40 retireat40 1 month ago
Very disappointing.
👍️0
LORTAP KCOTS LORTAP KCOTS 1 month ago
I’m cool with it sitting here for a bit, as we all know it’s either gonna be a 100x or bust
👍️ 1 💲 1
BubbaInSC BubbaInSC 1 month ago
shhhh pps goes down whenever confidence increases LOL

besides, RSI was overbought yesterday at 70ish
👍️0
Savannah-Marc Savannah-Marc 1 month ago
This should be fairly priced at $30 ! ! !
👍️ 1 🤡 1 🤣 1 🥇 1
LORTAP KCOTS LORTAP KCOTS 1 month ago
Yeah saw that $13.20 pre market trade.. thought dang this may go up today
🍎 1 👍️ 1
retireat40 retireat40 1 month ago
Idiots selling this morning. Was north of 13.
👍️ 1 📈 1
retireat40 retireat40 1 month ago
Thanks. May grab some of those today. Good luck.
👍️ 1 ♥️ 1
OmegaMoney29 OmegaMoney29 1 month ago
Captain 🧑‍✈️ we’re about to takeoff 🛫
Get your coffee ☕️
🌋 1 👍️ 1
OmegaMoney29 OmegaMoney29 1 month ago
Congrats
Got 10$,14s and 15 calls
👍️ 1 ♥️ 1

Your Recent History

NASDAQ
MNMD
Mind Medicine MindMed
TSX
TA
TransAlta
NASDAQ
HRYU
Hanryu
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved